A recent article on Kaiser Health News reported on a new drug for the treatment of hepatitis C for which the manufacturer charges $1,000 a pill, or $84,000 for a 12-week course of treatment.
Chronic hepatitis C is a leading cause of serious liver disease, including cancer.
It has been estimated that providing the drug to all patients known to have hepatitis C would substantially drive up budgets for public insurance programs and premiums for private insurance, though over the longer run there would be offsets to these upfront costs by obviating the need for alternative treatments, including liver transplants (see Pages 69-71 of the meeting summary from the California Technology Assessment Forum, linked to above).
The high price charged for the drug has led to street protests in San Francisco and calls for congressional hearings. It also provoked from The New York Times a stern editorial, “How Much Should Hepatitis C Treatment Cost?”
These reports brought to mind my post in November 2012. In that, I presented the above heuristic visual.
The horizontal line in this graph represents additional quality-adjusted life years (widely known in the research community as QALYs) wrestled from nature by a nation’s health system, arrayed in the increasing incremental costs per QALY gained. The vertical axis represents the incremental cost per additional QALY the health care system bestows on some patient.
I had called the solid line in the graph the QALY supply curve that the nation’s health system presents to society – the health system’s “offer curve,” in commercial parlance. A point on the line (e.g., Z) represents the most cost-effective (lowest cost) treatment capable of yielding the associated QALY. The treatment represented by point X would not be an efficient way to gain that QALY, because treatment Z is more cost-effective.
With this offer curve, a health system confronts the rest of the nation with two morally challenging questions:
1. Is there a maximum price above which society no longer wishes to purchase added QALYs from its health system, even with the most cost-effective treatments (e.g., Point C)?
2. Should that maximum price be the same for everyone, or could there be differentials – for example, a lower maximum price for patients covered by taxpayer-financed health programs (e.g., Medicaid, Tricare, the Veterans Administration health system and perhaps Medicare), a wide range of higher prices for premium-financed commercial insurance, depending on the generosity of the benefit package that the premium covers, and yet higher prices for wealthy people able to pay out of their own resources very high prices to purchases added QALYs for the family?
I tell my students that their parents and grandparents in the United States have always avoided confronting these morally taxing questions. They simply paid whatever was charged for whatever new medical technology came down the pike, letting per-capita health care spending grow annually at a long-term growth rate 2 to 2.5 percentage points above the growth in per-capita gross domestic product. The result has been spending far above the level of spending one observes in any other industrialized society (although we may implicitly have imposed a maximum price on QALYs for some Americans without health insurance).
But I also tell my students that they most likely will not be able to kick that particular can down the road much farther.
The Latest on: Quality-adjusted life years
[google_news title=”” keyword=”Quality-adjusted life years” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Quality-adjusted life years
- Paper Mario: The Thousand-Year Door Switch Frame Rate Revealedon April 25, 2024 at 7:30 pm
According to Nintendo's official description, the Switch version of Thousand-Year Door comes with "revamped graphics", which might explain the changes in performance. This newer release also includes ...
- Gaming and Leisure Properties Reports First Quarter 2024 Results and Updates 2024 Full Year Guidanceon April 25, 2024 at 3:15 pm
WYOMISSING, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) ("GLPI" or the "Company") today announced financial results for the quarter ended March 31, 2024.
- LoL Patch 14.9: LoL Players Happy With Quality Of Life Improvementson April 25, 2024 at 7:20 am
Riot has been adding small, yet effective quality of life changes to champions kits. This is something the community has taken note of and are pretty happy with, hoping Riot will keep it up. In the ...
- Public perception of ‘old age’ has shifted to later in lifeon April 24, 2024 at 1:21 pm
In a new study, researchers have explored how modern adults perceive the onset of old age compared to previous generations. The experts found that, as life expectancy increases and retirement ages are ...
- 5 Years After Avengers: Endgame, Marvel Is Still Struggling With Its Biggest Surpriseon April 24, 2024 at 7:17 am
On the anniversary of the Infinity Saga’s conclusion, we look back at the plot point that has continued to have the most complicated effect on the greater MCU.
- Humana Reports First Quarter 2024 Financial Results; Affirms Full Year Adjusted 2024 Financial Guidanceon April 24, 2024 at 3:30 am
Humana Inc. (NYSE: HUM) today reported consolidated pretax results and net earnings per share (EPS) for the quarter ended March 31, 2024 (1Q24) versus the quarter ended March 31, 2023 (1Q23) as noted ...
- Alexandria Real Estate Equities, Inc. Reports: 1Q24 Net Income per Share - Diluted of $0.97; and 1Q24 FFO per Share - Diluted, as Adjusted, of $2.35on April 22, 2024 at 1:10 pm
Alexandria Real Estate Equities, Inc. (NYSE: ARE) announced financial and operating results for the first quarter ended March 31, 2024.
- Lundin Gold: Buy Quality For Best Risk-Adjusted Returns In A Bull Marketon April 21, 2024 at 11:17 pm
Lundin Gold is a high-quality gold miner with a superior asset and an experienced management team. Learn why LUGDF stock is a Buy.
- Black Patients With Ovarian Cancer Had Lower-Quality End-of-Life Care, Study Sayson April 21, 2024 at 6:00 am
Non-Hispanic Black (NHB) patients with ovarian cancer (OC) receive lower-quality end of life (EOL) care compared to their non-Hispanic White (NHW) counterparts, according to a study.
- Madison house values rise 7.8% this year, assessment showson April 19, 2024 at 9:45 am
The value of the average single-family home jumped 7.8% to $457,300 for 2024, and the city saw a record $949.4 million in new construction.
via Bing News